Specialties:

Diagnosis and treatment of deafness, vertigo, facial paralysis, otitis media, tumors of lateral skull base as well as hearing screening and intervention on children.

Cochlear implant for severe or extremely severe sensorineural hearing loss (Minimally invasive technique for inner ear structure and residual hearing preservation, Complex cases of severe cochlear Malformation)

Ossicular train reconstruction for conductive hearing loss.

Member of the designated doctors for secondary screening and surgery under the National Cochlear implant Support Project of the Ministry of Health.

Clinical Interests:

Cochlear Implant, Otomicrosurgery, Transcanal endoscopic ear surgery and Lateral skull base surgery

Experience:

Jun.2004-present, Chief physician of Otolaryngology – Head and Neck Surgery

Guangdong Provincial People’s Hospital, Guangzhou, China

July. 2014-Mar. 2015, Visiting Scholar

Hyogo College of Medicine, Hyogo, Japan

Education:

Jun. 2003, Master’s degree

Otolaryngology, Sun Yat sen Medical University, Guangzhou, China.

Jun. 1988, Bachelor’s degree

Clinical Medicine, Shanghai Medical University, Shanghai, China

Awards and Honors:

TOP 10 DR in Otitis media Surgery of “TOP 100 Chinese Doctors List” in consecutive years. Honorary Title of “Good doctor in Yangcheng"

Designated doctors for secondary screening and surgery under the National Cochlear implant Support Project of the Ministry of Health.

Professional memberships:

1.Member , Academic Committee of the Key Laboratory of Auditory Medicine，Ministry of Health

2. Member, Otology group of Chinese society of Otolaryngology Head and neck surgery

3.Chairman, Otology Group of Guangdong Medical Doctor Association

4. Vice chairman, Hearing disability Committee of Guangdong Disabled Rehabilitation Association.

5. Expert member, hearing Professional Committee of Guangdong eugenics Association.

Publications:

Major publications are as follows.

[1] Yan Huang, Xiaoqian Wang, et al. Long-term outcomes of Cochlear Implantation in Irradiated ears of Nasopharyngeal Carcinoma Patients[J]. The Laryngoscope. 2021 03 ;131(3) :649-655. (Corresponding author)

[2] Li X, Tan B, Wang X, et al. Identification of a complex genomic rearrangement in TMPRSS3 by massively parallel sequencing in Chinese cases with prelingual hearing loss[J]. Molecular Genetics & Genomic Medicine, 2019. (Co-corresponding author)

[3] Tao Liu, Shaohua Chen, Xidong Wu, Hong Han, Siyi Zhang, Peina Wu, Xiaomei Su, Ting Wu, Shaobin Yu, Xiang Cai. Folate-Targeted pH and Redox Dual Stimulation-Responsive Nanocarrier for Codelivering of Docetaxel and TFPI2 for Nasopharyngeal Carcinoma Therapy. ACS Applied Bio Materials,2019, 2, 5, 1830-1841